SXTC
China SXT Pharmaceuticals, Inc.Company with tickers: SXTC
CIK
1723980
CUSIP
G2161P165
Shares Outstanding
4,458,077
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | $1,373,480 | USD | 2025-03-31 | 20-F | 2025-07-31 |
| Gross Profit | $367,427 | USD | 2025-03-31 | 20-F | 2025-07-31 |
| Operating Expenses | $3,047,906 | USD | 2025-03-31 | 20-F | 2025-07-31 |
| Research & Development | — | ||||
| Operating Income | $-2,680,479 | USD | 2025-03-31 | 20-F | 2025-07-31 |
| Net Income | $-3,303,652 | USD | 2025-03-31 | 20-F | 2025-07-31 |
| EPS (Basic) | $-2.32 | USD/shares | 2025-03-31 | 20-F | 2025-07-31 |
| EPS (Diluted) | $-2.32 | USD/shares | 2025-03-31 | 20-F | 2025-07-31 |